BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

832 related articles for article (PubMed ID: 17668067)

  • 1. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Klein SM; Aebischer P; Svendsen CN
    PLoS One; 2007 Aug; 2(8):e689. PubMed ID: 17668067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDNF delivery using human neural progenitor cells in a rat model of ALS.
    Klein SM; Behrstock S; McHugh J; Hoffmann K; Wallace K; Suzuki M; Aebischer P; Svendsen CN
    Hum Gene Ther; 2005 Apr; 16(4):509-21. PubMed ID: 15871682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Hayes A; Bellantuono I; Aebischer P; Svendsen CN
    Mol Ther; 2008 Dec; 16(12):2002-10. PubMed ID: 18797452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neural progenitors differentiate into astrocytes and protect motor neurons in aging rats.
    Das MM; Avalos P; Suezaki P; Godoy M; Garcia L; Chang CD; Vit JP; Shelley B; Gowing G; Svendsen CN
    Exp Neurol; 2016 Jun; 280():41-9. PubMed ID: 27032721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.
    Park S; Kim HT; Yun S; Kim IS; Lee J; Lee IS; Park KI
    Exp Mol Med; 2009 Jul; 41(7):487-500. PubMed ID: 19322031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
    Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
    Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
    Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
    J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model.
    Marconi S; Bonaconsa M; Scambi I; Squintani GM; Rui W; Turano E; Ungaro D; D'Agostino S; Barbieri F; Angiari S; Farinazzo A; Constantin G; Del Carro U; Bonetti B; Mariotti R
    Neuroscience; 2013 Sep; 248():333-43. PubMed ID: 23727509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS.
    Lepore AC; O'Donnell J; Kim AS; Williams T; Tuteja A; Rao MS; Kelley LL; Campanelli JT; Maragakis NJ
    PLoS One; 2011; 6(10):e25968. PubMed ID: 21998733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
    Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
    Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
    Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice.
    Kosuge Y; Sekikawa-Nishida K; Negi H; Ishige K; Ito Y
    Neurosci Lett; 2009 Apr; 454(2):165-9. PubMed ID: 19429077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors.
    Knippenberg S; Rath KJ; Böselt S; Thau-Habermann N; Schwarz SC; Dengler R; Wegner F; Petri S
    J Tissue Eng Regen Med; 2017 Mar; 11(3):751-764. PubMed ID: 25641599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects between bone marrow and mesenchymal stem cell transplantation in GDNF expression and motor function recovery in a motorneuron degenerative mouse model.
    Pastor D; Viso-León MC; Jones J; Jaramillo-Merchán J; Toledo-Aral JJ; Moraleda JM; Martínez S
    Stem Cell Rev Rep; 2012 Jun; 8(2):445-58. PubMed ID: 21717132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1
    Thomsen GM; Alkaslasi M; Vit JP; Lawless G; Godoy M; Gowing G; Shelest O; Svendsen CN
    Gene Ther; 2017 Apr; 24(4):245-252. PubMed ID: 28276446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model.
    Krakora D; Mulcrone P; Meyer M; Lewis C; Bernau K; Gowing G; Zimprich C; Aebischer P; Svendsen CN; Suzuki M
    Mol Ther; 2013 Aug; 21(8):1602-10. PubMed ID: 23712039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.